Warp Sciences
Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.
$215MSeries A
LeadL
Lightspeed
Activity from announced rounds
Activity in this selectionUnited States · Oct 23, 2026 · Sep 24, 2026
Lightspeed Venture Partners invests from seed through growth in enterprise, consumer, fintech and healthcare companies, with a global investment platform.
Its sector teams approach different company-building problems: enterprise adoption, changes in consumer behaviour, financial infrastructure and unmet clinical needs. The partnership includes former founders and operators with domain experience, so the relevant team depends on the business being built rather than a single firm-wide industry thesis.
Lightspeed’s healthcare practice focuses on technologies that can improve patient outcomes. In fintech, its stated interests span the financial technology stack, including blockchain, rather than being limited to consumer banking applications.
- Rounds participated in
- 3
- Confirmed lead rounds
- 2 All roles disclosed
- New companies
- 2 First participation on record · 1 follow-on
- Funding in participating rounds
- $463M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionDifferent
Runs AI demand generation for lean B2B marketing teams, connecting campaign planning, content, channel execution and optimization.
$48MSeed
ParticipantArena
Arena evaluates AI models through comparisons and observations of how people use them in real tasks.
$200MSeries B
Lead